Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
01 1Granules India Limited
02 2Sichuan Elixir Pharmaceuticals
03 1LGM Pharma
04 3Dr. Reddy's Laboratories
05 1Tagoor Laboratories
06 1Alembic Pharmaceuticals Limited
07 1Aurobindo Pharma Limited
08 1Baran Chemical and Pharmaceutical
09 1Beijing Mesochem Technology
10 1Biocon
11 1Guangzhou Tosun Pharmaceutical
12 1Hetero Drugs
13 1Hunan Huateng Pharmaceutical Co ltd
14 2MSN Laboratories
15 1Natco Pharma
16 1Shandong Haohong Biotechnology Co.,ltd
17 1Shanghai Hope Chem
18 1Shenzhen Haorui
19 1Sichuan Xieli Pharmaceutical
20 1Sterling Spa
21 1Sun Pharmaceutical Industries Limited
22 1Tecoland Corporation
23 1Vannsh Life Sciences
24 1Zhejiang Tianyu Pharmaceutical Co., Ltd
01 10China
02 14India
03 1Iran
04 1Italy
05 2U.S.A
01 10Active
02 18Blank
01 28Blank
01 28Blank
01 1WC-0349
02 1WC-0349A3
03 26Blank
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39757
Submission : 2024-03-22
Status : Active
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38207
Submission : 2023-03-31
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Sichuan Elixir Pharmaceutical, a manufacturer of small molecule APIs & a CMO/CDMO service provider for anti-tumor characteristic APIs..
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39785
Submission : 2024-03-26
Status : Active
Type : II
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39141
Submission : 2023-12-01
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39274
Submission : 2023-12-29
Status : Active
Type : II
NDC Package Code : 71796-059
Start Marketing Date : 2023-03-31
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2022-03-23
Pay. Date : 2022-02-28
DMF Number : 36509
Submission : 2022-02-28
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2019-12-17
Pay. Date : 2019-10-11
DMF Number : 34201
Submission : 2019-11-06
Status : Active
Type : II
We have 24 companies offering cabozantinib (S)-malate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?